Prospective Data Collection Initiative on Thoracic Malignancies (DuTOC)

June 6, 2025

Primary Outcome Measures

Progression free survival

Secondary outcome Measures

Disease free survival
Overall survival
Health related quality of life

Inclusion Criteria

Age ≥ 18 years;
Histo/cytopathological proof of a thoracic malignancy, or a strong suspicion (after imaging and multidisciplinary board);
Informed consent for longitudinal observational data collection;

Exclusion Criteria

Mentally challenged patients that are unable to provide conscientious informed consent as determined by the investigator.
Inability to provide a written or electronic informed consent.

CONTACT INFORMATION

Name*

First Last

Email*

Phone*

Address*

Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country

Have you received a diagnosis?*

Yes

DIAGNOSIS

Diagnosis?*

Date of Diagnosis*

Comments*

Name

This field is for validation purposes and should be left unchanged.

Quick Facts

Accepts Healthy Volunteers
Ages Available for Study
ClinicalTrials.gov Identifier
Collaborators
Contacts(s)
Location(s)
Estimated Enrollment
Estimated Study Start Date
Estimated Primary Completion Dates
Full Title
Genders Eligible for Study
Investigator(s)
Last Updated
Other Contact